Archive for the ‘Respiratory / Asthma’ Category
Wednesday, July 30th, 2008
This weekend Asthma UK will be teaming up with the British Heart Foundation and Diabetes UK to host a health marquee at the Birmingham Eid Mela, providing information and support for people from the South Asian community. The marquee will be run by staff, health professionals and volunteers, many of ...
Posted in Respiratory / Asthma | 1 Comment »
Wednesday, July 30th, 2008
It has previously been claimed that working as a baker involves, as a consequence, a great risk of evolving allergy and respiratory symptoms. The basis for this assumption was based on cross-sectional studies. In this study, undertaken by Tina Skjodt (Aarhus University Hospital, Aarhus, Denmark) and her team, bakers' apprentices ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, July 29th, 2008
Babies born extremely prematurely may be left with lung abnormalities in adulthood, such as emphysema, Australian researchers have found. The study, funded by the Raine Foundation, followed up babies born up to four months premature in the 1980s and weighing as little as 635 g. All of the young adults ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, July 29th, 2008
A significant proportion of the population (around 5% of men and 2% of women) experiences breathing difficulties during sleep. In most cases, these respiratory disturbances consist of periodic breathing obstructions followed by sudden short awakenings (up to 60 times per hour in severe cases). The patient suffering this disorder, technically ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, July 29th, 2008
Finalising a review of the safety of moxifloxacin-containing medicines for oral use, the European Medicines Agency (EMEA) has concluded that these medicines should only be prescribed in the treatment of acute bacterial sinusitis, acute exacerbation of chronic bronchitis and community-acquired pneumonia when other antibiotics cannot be used or have failed. ...
Posted in Respiratory / Asthma | No Comments »
Monday, July 28th, 2008
Bayer is pleased to announce that today theEuropean Medicines Agency's (EMEA) Committee for Medicinal Products forHuman Use (CHMP) proposed a labeling change for oral moxifloxacin for thetreatment of Acute Exacerbations of Chronic Bronchitis (AECB), AcuteBacterial Sinusitis (ABS) and Community Acquired Pneumonia (CAP) in linewith official European clinical guidelines. "We welcome ...
Posted in Respiratory / Asthma | No Comments »
Monday, July 28th, 2008
A research grant program that encourages "thinking outside the box" will allow a team of University of Iowa investigators to apply findings from heart research to the study of asthma.Specifically, the team has received a three-year, $750,000 grant from the Strategic Program for Asthma Research, known as SPAR, to see ...
Posted in Respiratory / Asthma | No Comments »
Monday, July 28th, 2008
Talecris Biotherapeutics, Inc. announced today that the European Commission followed an opinion of the Committee for Orphan Medicinal Products (COMP) and has granted orphan drug designation to Talecris' alpha-1 proteinase inhibitor (human) for inhalation use in the treatment of congenital Alpha1-Antitrypsin Deficiency (also known as AAT Deficiency or Alpha-1). Currently, ...
Posted in Respiratory / Asthma | No Comments »
Sunday, July 27th, 2008
Asthma UK Scotland is looking for 15-year-olds across Scotland with asthma to act as ambassadors for the charity and encourage other youngsters to lead a full and active lifestyle. One 15-year-old from each of Scotland's 14 health board areas will be chosen to co-ordinate innovative activities - in ...
Posted in Respiratory / Asthma | No Comments »
Sunday, July 27th, 2008
A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette ...
Posted in Respiratory / Asthma | No Comments »
Friday, July 25th, 2008
The University of Oxford and Emergent BioSolutions Inc. (NYSE:EBS) has announced that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd. (the "Consortium"), to further develop MVA85A, the world's most clinically advanced vaccine candidate for the prevention of tuberculosis. The University of Oxford, through its technology transfer ...
Posted in Respiratory / Asthma | No Comments »
Wednesday, July 23rd, 2008
When the price of cigarettes topped ten dollars a pack at some city outlets last month, thousands of smokers knew it was time to quit. An analysis of data from the city's 311 line showed the number of calls for help to quit smoking was three times higher during ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, July 22nd, 2008
Recent studies have shown that bosentan therapy greatly improves the quality of life for patients with pulmonary arterial hypertension (PAH). According to a study in Respirology published by Wiley-Blackwell, treatments with oral Bosentan reduces resistance in blood flow - allowing the heart and lungs to work more efficiently ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, July 15th, 2008
Theravance, Inc. (NASDAQ: THRX) announced the positive results from a Phase 2 study of the lead investigational compound GSK961081 ('081) in the inhaled bifunctional muscarinic antagonist-beta2 agonist (MABA) program. The MABA program was licensed to GlaxoSmithKline (GSK) in 2007 under the terms of the companies' Strategic Alliance Agreement ...
Posted in Respiratory / Asthma | No Comments »
Tuesday, July 15th, 2008
Americas Watchdog has created the most useful service for victims or family members of victims of Mesothelioma available in the US. Mesothelioma is a rare, and lethal form of cancer. Mesothelioma is caused by exposure to asbestos. The group never realized that there was no safety net for victims, ...
Posted in Respiratory / Asthma | No Comments »
